Prepare for your visit
Joan T Meaney
Urology · San Antonio, TX · NPI 1710967831
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,603.76
in general payments reported to CMS, 2019-2025 · $176 in 2025
The $176 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Who reported paying
General payments only, top 6 by amount.
- Astellas Pharma US INC $638.24
- Sumitomo Pharma America, INC. $336.23
- Therapeuticsmd, INC. $280.64
- Urovant Sciences INC $261.48
- Boston Scientific Corporation $27.98
- Abbvie INC. $27.95
Drugs and devices associated with these payments
Gemtesa Avycaz Lumenis Pulse 120h Myrbetriq Veozah
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Joan Meaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/33074/joan-t-meaney